MedPath

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3

Not Applicable
Completed
Conditions
Healthy Participants
Registration Number
NCT03572985
Lead Sponsor
Taisho Pharmaceutical Co., Ltd.
Brief Summary

The purpose of this study is to collect alcohol calibration data for the driving simulator.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
25
Inclusion Criteria
  • Body mass index (BMI) ≥18.5 and <25.0 kg/m^2 at screening inspection
  • No visual impairment (enable to correct the vision with eyeglasses or contact lens)
  • Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study
Exclusion Criteria
  • History of drug and food allergy
  • Alcohol dependence, drug dependence or abnormal drunken (including past history)
  • Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Standard Deviation of Lateral Position (SDLP)60 min
Secondary Outcome Measures
NameTimeMethod
Brake Reaction Time (BRT)5 min
Distance Coefficient of Variation (DCV)5 min

Trial Locations

Locations (1)

Taisho Pharmaceutical Co., Ltd selected site

🇯🇵

Fukuoka, Japan

Taisho Pharmaceutical Co., Ltd selected site
🇯🇵Fukuoka, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.